Monday, August 24, 2026
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Peer-reviewed paperarXiv

Unbalanced optimal transport for robust longitudinal lesion evolution with registration-aware and appearance-guided priors

View original at arxiv.org
{ "id": "2602.09933v1", "url": "http://arxiv.org/abs/2602.09933v1", "title": "Unbalanced optimal transport for robust longitudinal lesion evolution with registration-aware and appearance-guided priors", "summary": "Evaluating lesion evolution in longitudinal CT scans of can cer patients is essential for assessing treat…
Opening lines of the source · arXiv · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Accurate detection of merging and splitting lesions is crucial for reliable response evaluation, as overlooking these events can lead to misclassification under RECIST and potentially incorrect assessment of disease progression

    80% confidence
  • Standard bipartite matchers which rely on geometric proximity struggle when lesions appear, disappear, merge, or split

    80% confidence
  • This is the first approach to cast longitudinal lesion correspondence as a UOT problem, providing a principled alternative to distance-based bipartite matchers

    80% confidence
  • The proposed method produces interpretable lesion evolution graph with persistent, new, disappearing, merging, and splitting events without requiring heuristics or training data

    80% confidence
  • UOT achieves consistently higher edge-detection precision and recall, improved lesion-state recall, and superior lesion-graph component F1 scores versus distance-only baselines

    80% confidence

Cited in these Via News reports